An in-vivo but non-animal test system for cell recruitment and cell integration into the heart
PhDs and postgraduate research
Self-funded PhD students only
School of Pharmacy and Biomedical Sciences
October and February
Applications accepted all year round
The PhD will be based in the Faculty of Science and Health, and will be supervised by Dr Susanne Dietrich, Dr Anthony Lewis and Dr Aikaterini Lalatsa who will combine their expertise in heart development, heart beat control and cell-supporting biomaterials.
The work on this project involves:
- Making novel discoveries underpinning therapy development by unravelling
- how cells are recruited and integrated into a beating heart,
- how cells are instructed to follow a pre-existing heart beat;
- Testing novel biomaterials – can biomaterials support cell delivery to the heart ?
- Learning / applying a wide range of laboratory techniques including cell and embryo culture, techniques to monitor gene/ protein expression profiles, various microscopical techniques and biomaterials preparation
Cardiovascular disease is the most prevalent cause of death, because it frequently leads to a fatal stroke or heart attack. In a heart attack, blood and oxygen supply to the beating heart cells becomes obstructed, and as a consequence, heart muscle cells perish.
Current efforts aim to develop therapeutic cells that can replace the lost cells and restore heart function. This however has not been achieved because exogenously generated cells fail to integrate into the framework of the existing heart and to beat in tune, causing potentially fatal arrhythmias1.
In the embryo, a cell population exists that is recruited and integrated into the primitive, already beating heart2. How the integration of these so-called secondary heart field cells is facilitated is not known.
This project will use the chicken embryo in the egg as an in-vivo but non-animal test system for cell recruitment and cell integration into the heart. The project will first investigate, how cell recruitment and integration works. Thereafter, the project will establish whether tissue-culture-grown, potential therapeutic human cells can integrate into the primitive heart in the same fashion as the normal embryonic cells.
To monitor cell recruitment, fluorescently labelled cells will be transplanted into the secondary heart field of early stage chicken embryos; cell contribution to the heart and cell beating will be assessed by fluorescence videomicroscopy.
To monitor cell integration, changes in marker gene expression, cell shapes and cell-to-cell contacts will be recorded, using in situ hybridisation and immunohistochemistry, alongside quantitative methods such as qPCR. There will be a particular focus on the expression of ion channels which control beating. To develop a platform for the evaluation of human cells, biomaterials will be tested for their ability to present the cells to the existing heart for recruitment3.
- Scuderi, G.J. and J. Butcher, Naturally Engineered Maturation of Cardiomyocytes. Front Cell Dev Biol, 2017. 5: p. 50
- Wittig, J.G. and A. Munsterberg, The Early Stages of Heart Development: Insights from Chicken Embryos. J Cardiovasc Dev Dis, 2016. 3(2).
- Moshayedi, P., et al., Systematic optimization of an engineered hydrogel allows for selective control of human neural stem cell survival and differentiation after transplantation in the stroke brain. Biomaterials, 2016. 105: p. 145-155.
Fees and funding
Funding availability: Self-funded PhD students only.
PhD full-time and part-time courses are eligible for the UK Government Doctoral Loan (UK and EU students only).
2020/2021 entry (for October 2020 and February 2021 entries)
Home/EU/CI full-time students: £4,407 p/a
Home/EU/CI part-time students: £2,204 p/a
International full-time students: £16,400 p/a
International part-time students: £8,200 p/a
PhD by Publication
External candidates £4,407 p/a
Members of staff £1,680 p/a*
2021/2022 entry (for October 2021 and February 2022 entries)
PhD and MPhil
Home/EU/CI full-time students: £4,407 p/a*
Home/EU/CI part-time students: £2,204 p/a*
International full-time students: £17,600 p/a
International part-time students: £8,800 p/a
All fees are subject to annual increase.
PhD by Publication
External Candidates £4,407 p/a*
Members of Staff £1,720 p/a*
If you are an EU student starting a programme in 2021/22 please visit this page.
*This is the 2020/21 UK Research and Innovation (UKRI) maximum studentship fee; this fee will increase to the 2021/22 UKRI maximum studentship fee when UKRI announces this rate in Spring 2021.
Some PhD projects may include additional fees – known as bench fees – for equipment and other consumables, and these will be added to your standard tuition fee. Speak to the supervisory team during your interview about any additional fees you may have to pay. Please note, bench fees are not eligible for discounts and are non-refundable.
You'll need an upper second class honours degree from an internationally recognised university or a Master’s degree in an appropriate subject. In exceptional cases, we may consider equivalent professional experience and/or qualifications. English language proficiency at a minimum of IELTS band 6.5 with no component score below 6.0.
Experience in cell/ developmental biology is desirable.
How to apply
We’d encourage you to contact Dr S. Dietrich at firstname.lastname@example.org to discuss your interest before you apply, quoting the project code.
When you are ready to apply, you can use our online application form. Make sure you submit a personal statement, proof of your degrees and grades, details of two referees, proof of your English language proficiency and an up-to-date CV.
Our ‘How to Apply’ page offers further guidance on the PhD application process.
If you want to be considered for this self-funded PhD opportunity you must quote project code PHBM4711020 when applying.